(1R,3aR,10bR)-1-ethyl-3a,4,5,6-tetrahydro-1H-furo[3,2-c]pyrrolo[1,2-a]azepin-2(10bH)-one

ID: ALA4777367

PubChem CID: 162643889

Max Phase: Preclinical

Molecular Formula: C13H17NO2

Molecular Weight: 219.28

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@H]1C(=O)O[C@@H]2CCCn3cccc3[C@H]21

Standard InChI:  InChI=1S/C13H17NO2/c1-2-9-12-10-5-3-7-14(10)8-4-6-11(12)16-13(9)15/h3,5,7,9,11-12H,2,4,6,8H2,1H3/t9-,11-,12-/m1/s1

Standard InChI Key:  NDLADSYOFYAUIS-YUSALJHKSA-N

Molfile:  

 
     RDKit          2D

 18 20  0  0  0  0  0  0  0  0999 V2000
   39.3185   -9.4168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.0560   -9.0737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.7904   -9.4364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.6316  -10.8583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.1263  -10.2163    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.3595  -10.4984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.3909  -11.3148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.1771  -11.5372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.9684  -10.2339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4497  -10.8641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.8888  -11.5522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6789  -11.3472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.7280  -10.5325    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   42.3099  -11.8665    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   40.5898  -12.3127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.3713   -9.5215    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   40.0341  -11.5686    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   41.0990  -12.9519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  1  5  1  0
  3  9  1  0
  4 10  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  4  2  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13  9  1  0
 12 14  2  0
 11 15  1  6
  9 16  1  6
 10 17  1  1
 15 18  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4777367

    ---

Associated Targets(Human)

HCT-8 (3484 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 219.28Molecular Weight (Monoisotopic): 219.1259AlogP: 2.32#Rotatable Bonds: 1
Polar Surface Area: 31.23Molecular Species: NEUTRALHBA: 3HBD:
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 2.21CX LogD: 2.21
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.68Np Likeness Score: 0.34

References

1. Ma K,Zhang M,Wu X,Yang P,Yin C.  (2021)  Discovery of a potent β-catenin destabilizer for overcoming the resistance of 5-fluorouracil in colorectal cancer.,  30  [PMID:33321421] [10.1016/j.bmc.2020.115929]

Source